The attachment of embryo on the endometrial surface and subsequent invasion into endometrial stromal tissues are essential processes for human embryo implantation. The maternal endometrium is considered to receive embryo implantation during the limited period, so-called implantation window. This period may be regulated mainly by ovarian sex steroid hormones such as estrogen and progesterone. However, the precise mechanism for regulation of endometrial receptivity for human embryo remains unclear and there has been few direct evidence to show the periodic changes of human endometrial receptivity during the menstrual cycle.
The attachment assay using human endometrial epithelial cells (EECs) and BeWo cell spheroids, which is a human choriocarcinoma-derived cell line, the majority of spheroids attached on the EECs obtained from women in the mid-secretory phase. However, few spheroids could attach on the EECs derived from other phases, suggesting that some adhesion-interfering substances exit in these EECs. EECs treated with proteases significantly enhanced their ability to receive spheroid attachment, supporting the above speculation. In addition, attached spheroids were significantly increased on the EECs that were co-cultured with PBMC. These findings suggest that immune system as well as proteases secreted from endometrial glands or developing embryo play some roles in regulation of endometrial receptivity for human embryo.
In Matrigel invasion assay. human PBMC promoted murine embryo spreading and invasion. This effect is higher in PBMC derived from pregnant women than in those from non-pregnant women . BeWo cell invasion was also promoted by PBMC derived from pregnant women and chemoattractive soluble factors secreted from PBMC were shown to induce BeWo cell invasion. These invasion-promoting effects were enhanced by HCG treatment. In addition. HCG increased IL-8 production by PBMC , and not LH/HCG receptor, but glycosilated-sites of HCG were speculated to mediate this reaction. Furthermore, human extravillous trophoblasts isolated from primary villous explant culture expressed a chemokine receptor . CCR1. and their invasion was enhanced by RANTES.
These findings suggest that immune system also regulates embryo attachment on EECs and invasion into endometrial stromal tissues in cooperation with endocrine system. Symposium II 1. The gene related gamesomeness Naoki Takeshita Department Obstetrics and Gynecology, TOHO University School of Medicine Owing to recent advances in molecular biology. Y chromosome genes associated with spermatogenesis have been identified. In 1976. Tiepolo and Zuffardi first reported a correlation between long arm of Y chromosome deletions and azoospermic men. Therefore, several studies demonstrated that deletions in a specific region on the long arm of the Y chromosome (Yq) result in spermatogenic failure. This region was later identified to be AZoospermic Factor (AZF). At present four different AZF regions (AZFa, AZFb. AZFd and AZFc) have been reported. In addition. numerous candidate genes of AZF have also been reported by many authors such as DAZ. RBMY. USP9Y. and DBY. Especially DAZ (Deleted AZoospermia), in which the AZFc gene is located. is strongly suspected to be an azoospermic factor. The microdeletion of DAZ on infertile men is higher than that in other genes. The human DAZ gene family contains a cluster of DAZ genes and a single autosomal homologue, DAZLA, in which located chromosome 3p24. The DAZL gene is highly homologous to the DAZ gene, with an around 80% similarity in the coding region of the cDNA. However, the mechanism of DAZLA remains to be elucidated. DAZLA may play an important role in the mitosis and meiosis on human spermatogenesis. Also it is recognized on ovarian tissue. The purpose of this study is to assess the DAZLA gene expression during gametogenesis. Mitochondrial DNA also is considered to related gametogenesis. In this study, we assess to analyze for Y chromosome microdeletion, DAZLA gene, and mtDNA (Mitochondrial DNA). It's so important to have counseling for infertility couple.
Application of vitrification for clinical practice Hidekazu Saito National Center for Child Health and Development
Techniques for in vitro fertilization and embryo transfer have improved a great deal during the last years and as a result, many more pregnancies have been established. This improvement comes accompanied by a higher rate of multiple pregnancy. Multiple pregnancy is associated with various complications including threatened abortion and premature delivery, fetal malformation, need of cervical ligation and caesarean section.
greater uterine bleeding at birth. and babies with low birth weight. Decreasing the number of embryos transferred into the uterus is one of the best approaches to prevent multiple pregnancies. As a result. several embryos are left to be stored for future embryo transfer.
Since Whittingham first successful mouse embryo freezing and thawing. many researchers have investigated new ways to improve the method. Various possibilities have been studied like changing the cryoprotectant, or using different freezing and thawing methods. According to the freezing method proposed by Whittingham, it takes 2 to 3 hours for embryos to be frozen with minimal ice formation in embryo blastomeres. To avoid the lethal effect of ice formation, Luyte drew attention to the feasibility of using vitrification for biological material. Rall and Fahy applied the vitrification method to cryopreserve mouse embryos using dimethyl sulfoxide, acetamide, propylene glycol and polyethylene glycol. However. embryos exposed for too long to this cryoprotectant at room temperature were adversely affected by the solution and its high concentration required to properly vitrify embryos. Therefore, this procedure allowed only a very short time for embryos to equilibrate with the cryoprotectant. Kasai developed a less toxic cryoprotectant, composed of modified phosphate buffer solution, ethylene glycol. ficoll and sucrose. He showed that the optimal equilibration time in the vitrification solution before rapid cooling varied with the ambient temperature according to the criterion of blastocyst formation rate. Meanwhile. we modified Kasai's cryoprotectant and used trehalose instead of sucrose. We examined the optimal equilibration time when the temperature of cryoprotectant was fixed at 5'C aiming to allow longer optimal equilibration time to slowly and steadily handle embryos. To detect possible DNA damage to mouse embryos during our vitrification procedure, we used the sister chromatid exchange technique. This study showed that the lowest DNA damage on embryos occurred when they were equilibrated in the solution for 5 minutes before freezing.
Based on our successful results with vitrification of mouse embryos, we examined the potentiality of applying the method to human embryos. In my lecture today, I would like to explain the key points of the clinical application of vitrification to human embryos and oocytes.
3. Fertilization failure after ICSI and the effect of ICSI on embryo development Kaoru Yanagida International University of Health and Welfare Intracytoplasmic sperm injection (ICSI) is effective for functional disorders. such as the disorders of capacitation, acrosome reaction, and sperm-egg fusion in the process of fertilization. ICSI is a revolutionary treatment for severe male infertility and unfertilized cases in IVF, since ICSI has the highest fertilization rate. But there are some cases for which ICSI is not effective completely. Here, I discuss about the fertilization failure in ICSI and best plan to fertilization failure, especially artificial oocyte activation. ICSI 1. Fertilization failure after ICSI Of the 1779 treatment cycles, there have been 100 treatment cycles of completely fertilization failure in ICSI. 13% of them failed to achieve fertilization after each repeatedly ICSI. It seemed that fertilization failure was due to oocyte activation by analysis with chromatin staining of oocytes. For the failure of oocyte activation, we could apply artificial oocyte activation combined with ICSI. The method of oocyte activation with successful pregnancy reported were Ca2+ ionophore treatment and electrical stimulation. The former was reported by Hoshi et al (1994) , the later was reported by Yanagida et al (1999) . This procedure was confirmed effectiveness. 8 babies (7 pregnancies) were born from the treatment of oocyte activation (electrical stimulation) with ICSI. 2. Effect of ICSI on the embryo development
The incidence of blastocyst formation after ICSI was lower as compared with the IVF group. The process of decondensation of spermatozoa in ICSI was delayed as compared with the IVF. Testicular spermatozoa that contained low SS bonds in nucleoprotein can begin the decondensation as compared with epidydimal and ejacurated spermatozoa. In mice. at 96 hs after insemination or injection, cell number of embryos obtained after ICSI with testicular spermatozoa was high as compared with those obtained with epidydimal spermatozoa .
Spermatozoa with poor SS-bonds in nucleoprotein might be favorable to obtain good embryos in ICSI.
Blastocyst culture and development Koichi Kyono Ladies Clinic Kyono
The advantages of blastocysts culture are 1) multiple pregnancy reduction following the decrease of transferred embryos. 2) synchronization of day 5 blastocysts with endometrium , 3) confirmation of embryo quality and development, and 4) decrease of uterine contractions and cervical mucus. Day 5 blastocysts transfer rate has been increased with the advent of newer culture systems . But now, It is not clear which is better in clinical pregnancy rates per oocyte retrieval between on day 3 and day 5 embryos transfer . I would like to state the outcome of the present blastocysts culture and development , and the future strategy of improvement of acquirement of good quality oocytes and blastocysts .and male factor, luteal support.
Influence to the multipe pregnancy of ART Minako Matsumoto Seirei Hamamatsu General Hospital
With the recent spread of assisted reproductive technology (ART), about 1% of newborns in Japan are born by ART, and the incidence of multiple pregnancy is increasing . Compared with single pregnancy, multiple pregnancy shows a high incidence of maternal complications and premature deliveries and is an important problem in perinatal medicine. Among multiple pregnancies, super twins (triplets or more) and monochorionic multiple pregnancy have particularly high risks . Super twins have been conventionally managed by limiting the number of transferred embryos. After introduction of blastocyst transfer with high selectivity of good embryos, the incidence of monochorionic multiple pregnancy has been increasing . At our hospital, IVF-ET has been performed since 1989. Initially, the multiple pregnancy rate was 36 .8%, and there were 4 quadruplet pregnancies. Reflecting these results, we limited the number of transferred embryos to 3 in 1991 and to 2 in 1998. However, since the introduction of blastocyst transfer in 1999 , the incidence of monochorionic multiple pregnancy has been increasing. Therefore. we evaluated the multiple pregnancy rate after limitation of the Loss of calmegin, a testis-specific putative chaperone protein of the endoplasmic reticulum, leads to male sterility because the sperm show defects in migration into the oviduct and do not bind to the zona pellucida. To clarify the mechanism of defective migration. XY-XY chimeras were produced by aggregating wild-type embryos with embryos of transgenic mice lacking functional calmegin genes and expressing green fluorescent protein (GFP) in their acrosomes. Chimeric ejaculates contained wild-type non-fluorescent sperm as well as sperm with GFP-tagged acrosomes and the defective calmegin gene. Transgenic, wild-type, and chimeric males were mated to wild-type females; however, only wild-type sperm were ever found within the oviducts. Calmegin knockout sperm, even when they were combined in chimeric ejaculates with wild-type sperm, remained outside of the uterotubal junction (UTJ). These findings indicate that the presence of wild-type sperm cannot compensate for the inability of calmegin knockout sperm to enter the oviduct and that successful ascent into the oviduct depends on the capabilities of individual sperm.
2. The expression of oocyte activation in spermaids Fumi Tanaka, Ai Kazami, Kahei Sato Depatment of Applied Life Science, Graduate School of Bioresource Sciences, Nihon University, Kanagawa, Japan Spermatids, precursor of male gametes, are known to possess the potential to achieve fertilization and embryonic development when injected into eggs. However, injection of round spermatids alone seldom activates eggs in the mouse. The unification of sperm and egg leads to distinctive series of cytosolic Ca++ oscillations that are prerequisite for normal embryo development. It is reported that elongated spermatids have the potential of oocytes activation. Although activating abilities of spermatids expresses during spermiogenesis, the exact time remains unknown. Objectives: It has been shown that anti-sperm antibodies (ASA) are produced both in males and females. Some of ASA significantly relate with refractory infertility by inhibiting sperm passage through female reproductive tract or by blocking sperm-egg interaction.
In some autoimmune diseases, disease incidence and disease severity have been shown to differ between males and females. In the present study, the activity of sperm-immobilizing antibodies (SIA) was compared between infertile males and females. Results: The incidences of SIA in females and males were 2.8% (25/887) and 0.9% (10/1072), respectively. There was a significant difference between the 2 groups (P<0.005).
Three (18.8%) of 16 females with SIA.
none (0%) of 5 males with SIA, and 42 (76.4%) of 55 patients without SIA had the normal results in PCT.
There was no difference between the former 2 groups (P>0.05). After the treatments, 13 (54.2%) of 24 females with SIA and 8 (80.0%) of 10 males with SIA conceived (P>0.05). In total. 15 pregnancies from 13 females and 10 pregnancies from 8 males were established. In females, 2 (13.3%), 2 (13.3%), 10 (66.7%). and 1 (6.7%) pregnancies were established by TI, AIH, IVF-ET, and ICSI-ET, respectively. In males, 1 (10%), 1 (10%), 2 (20%). and 6 (60%) pregnancies were established by TI, AIH, IVF-ET, and ICSI-ET, respectively.
There was a significant difference of the ICSI-ET pregnancy rates between the 2 groups (P<0.005).
Conclusions:
Disease incidence of ASA. especially SIA, seems to differ between males and females.
The significantly higher necessity of ICSI-ET indicates that some ASA on the sperm surface cause fertilization failure. These findings suggest that there are gender differences in anti-sperm immunity in human. Methods: HamZPA cDNA was isolated by a degenerate RT-PCR technique using mRNA prepared from 3-week old hamster ovaries and primers designed based on nucleotide sequence of highly-conserved regions among other species. A partial recombinant hamZPA protein (rec-hamZPA) was produced in Escherichia coli using pET21 vector and used for immunization of female hamsters. After the third injection, sera were collected and assayed for antibody production by western blotting and immunofluorescent staining.
Results: A 747 base-pair partial hamZPA cDNA encoding 249 amino acids was isolated. The homology of hamZPA with ZPA of rat. mouse, human and pig was 69.0, 64.7, 53.0 and 44.9%. respectively. The antisera produced by immunization of hamsters with the rec-hamZPA specifically reacted to native hamster zona pellucida. Conclusion: These results suggested that rec-hamZPA is useful to study a contraceptive vaccine in the homologous system. HLA-G were able to be successfully implanted. After this report, Lierop et al attempted to duplicate these results. although they were not able to demonstrate same results. Since this finding could have a significant impact on in vitro fertilization, we decided to investigate this question using novel reagents.
Method: We prepared 106 culture supernatants that were collected after 3 days culture or 4-6 days culture following in vitro fertilization. These samples were measured by sandwich ELISA using the specific monoclonal antibodies for HLA-G, 87G and MEMG/9.
Results: We could correctly detect soluble HLA-G in control samples that contained above 5 ng/ml of soluble HLA-G However, we were unable to detect soluble HLA-G in all of samples we investigated. and to find any relation between actual value and successful implantation. RESULTS: Lymphocytes appeared in the transplanted tissues were stained with human antigen. Some human CD56-positive cells were detected in stroma of the tissue before transplantation. However, they had disappeared by 14 days after transplantation. A few were observed at 21 days, then they significantly increased in number in stroma by day 28.
CONCLUSIONS: It is suggested that CD56-positive uterine NK cells were in situ proliferation in endometrial stroma rather than derived from the peripheral blood.
11. Endometrial hyperplasia in IL-2 receptor beta-chain transgenic mice Ken Kusakabe, Zhong-Lian Li, Yoshinori Otsuki Osaka Medical College IL-2 receptor is composed of alpha. beta and gamma-chains and IL-2 receptor beta-chain is essential for the high affinity between IL-2 receptor and IL-2 or IL-15 and for signal transduction. In IL-2 receptor beta-chain transgenic (Tg2Rbeta) mice, cystic changes are frequently observed in uterus. The present study was conducted to examine the pathological changes in the uterus of Tg2Rbeta mouse and the involvement of immunological system in the causes.
Wild type (WT) or Tg2Rbeta mice were determined by genotyping assay of tail tissue. Uterus and blood were collected at young age (8-12 wks), middle age (24-32 wks) and old age (over 40 wks), respectively. By immunohistochemistry, estrogen receptor (ER) alpha, proliferating cell nuclear antigen (PCNA) and IL-2 receptor beta-chain were examined in the uterus. and by ELISA, the serum revel of estradiol was measured.
Appearances of natural killer (NK) cells and macrophage were examined by immunohistochemistry and Western blotting, and concentration of tumor necrosis factor (TNF)-alpha in uterus. which is derived from NK cells. was measured by ELISA.
Endometrial hyperplasia (EHP) was frequently observed in 83.3% of old Tg2Rbeta mice. while only 50.0% in old WT mice, and the incidences of EHP increased depending on age in both types of mice. Cystic endometrium of EHP-caused Tg2Rbeta mice was positive for PCNA. No differences were observed in the serum level of estradiol and expression of ER alpha in uterus. In addition, NK cells and macrophages could not be detected and concentration of TNF-alpha in uterus was same level in both types of mice. On the other hand, endometrium in Tg2Rbeta mice was positive for IL-2 receptor beta-chain obviously. although it was weakly expressed in the endometrium of WT mice.
We demonstrated that there was spontaneous EHP in Tg2Rbeta mice. The onset of EHP in Tg2Rbeta mice was suggested to be estrogen-independent. and to be associated with direct affect of IL-2 or IL-15 though IL-2 receptor beta-chain in endometrium. Tg2Rbeta mouse may be a useful model for the study of EHP. Expression of other endometrial gland differentiation marker protein such as leukemia inhibitory factor and interleukin-1 receptor was also enhanced by HDACi at both mRNA and protein levels. Reporter assay using glycodelin promoter region revealed that the promoter activity was enhanced by HDACi treatment in a dose-dependent manner in a similar way to ovarian steroid hormone stimulation. Enlarged and flattened morphological changes and actin rearrangement were also induced by the exposure of HDACi without ovarian steroid hormones. These results collectively suggest that histone acetylation is deeply involved in differentiation of EGCs together with up-regulation of glycodelin expression.
13. Expression profiles of potential chemoattractants for peripheral blood CD16-negative natural killer cells in human endometrium Kotaro Kitaya, Nobue Daikoku, Takeshi Yamaguchi, Hideo Honjo Kyoto Prefectural University of Medicine Human endometrium is infiltrated by CD16-negative natural killer (NK) cells throughout the menstrual cycle. The number of endometrial CD16-negative NK cells is low in the proliferative phase, but acutely rises after ovulation, and peaks in the mid-to late secretory phase. Although the underlying mechanism explaining the postovulatory rise of endometrial CD 16-negative NK cells remains yet unknown, selective recruitment from peripheral blood (PB) CD16-negative NK cells is a possible theory. We investigated the expression of the potential chemoattractants for PB CD 16-negative NK cells in the human endometrium. Of chemokines examined. we found that macrophage inflammatory protein (MIP)-lbeta, RANTES, monocyte chemoattractant protein (MCP)-2. MCP-3. MCP-4, 6Ckine. MIP-3beta, interferon-inducible protein (IP)-10, and monokine induced by gamma-interferon (Mig) were expressed, whereas MIP-1 alpha, interferon-inducible T cell alpha-chemoattractant, and stromal cell-derived factor-1 were not. Although there were some differences in their expression patterns. their overall expression levels. especially in the vascular or perivascular area, were higher in the secretory phase than in the proliferative phase. Progesterone was a positive regulator of secretion of MIP-1 beta, MCP-3, MCP-4. IP-10. and Mig from cultured endometrial stromal cells, but not of 6Ckine or MIP-3beta. By contrast. 17-beta estradiol had no significant effect on their secretion. These results support the idea that endometrial CD16-negative NK cells are recruited selectively from PB CD16-negative NK cells.
14. The expression and effect of fibulin-1 during decidualization in human endometrial stromal cell induced by progesterone Tsuyoshi Nakamoto, Hidetaka Okada, Tatsuya Nakajima, Katsuhiko Yasuda, Hideharu Kanzaki Kansai Medical University Fibulin-1. an extracellular matrix as well as plasma glycoprotein, is distinct component of vessel walls. It was also found to inhibit cell motility and adhesion. We previously reported that progesterone stimulated the expression of fibulin-1 mRNA in endometrial stromal cells (ESCs). In the present study. we tried to clarify the spatial and temporal regulation of fibulin-1 by progesterone in human endometrium. Real-time PCR revealed a significant increase in fibulin-1 mRNA expression in ESCs treated with 6 a -methyl-17 -hydroxy-progesterone acetate (MPA) or 8 bromoadenosine 3': 5'-cyclic monophosphate (8-Br-cAMP) compared with vehicle. Furthermore. MPA was a potent inducer of fibulin-1 mRNA expression in a dose dependent manner. Additionally. RU-486 almost completely inhibited MPA-induced fibulin-1 mRNA. On the other hand, 17 f3 -estradiol (E2) alone did not increase fibulin-1 mRNA expression. To describe the menstrual cyclic regulation in vivo. real-time PCR and immunohistochemistry was performed in proliferative (Pro) and secretary (Sec) phases. Higher fibulin-1 mRNA expression was observed in Sec than in Pro phase. Fibulin-1 protein was expressed in glandular epithelia in Pro phase, but expression switched to the stroma in Sec phase. Small interfering RNA to inhibit fibulin-1 mRNA expression was added to ESCs culture, treated with MPA and 8-Br-cAMP, but no significant decrease of prolactin mRNA expression was observed. These results suggest that fiblin-1 is deeply involved in human endometrial decidualization induced by progesterone.
Effects of Allograft Inflammatory
Factor-1 (AIF-1) on cytokine productions in vitro study Ryutaro Nishida 1, Shimada RESULTS: As previously shown. we detected HLA-G expression on extravillous trophoblasts, and found
G-CSF inhibits
HLA-E expressed weakly on all trophoblasts in all stages. Weak expression of HLA-F was found on all types of trophoblasts, however HLA-F was expressed strongly on the extravillous trophoblasts that had invaded the maternal decidua.
CONCLUSION:
We found that HLA-F is expressed not only on the villous trophoblasts but also on the extravillous trophoblasts in all stages of pregnancy. We speculate that HLA-E, -F, and -G together may collaborate in the protection of fetus from maternal immune cells. University School of Medicine; 2 Sapporo Maternity Womens 'Hospital Objectives: By prospective study. to determine the prevalence of a variety of antiphospholipid antibody (APL) and to evaluate pregnancy outcomes of women with APL.
Methods: The eight hundred forty-one pregnant women in the first trimester were enrolled in this study. Six kinds of APLs included lupus anticoagulant (LA), anticardiolipin (aCL) IgG / IgM / IgA, and anti-prothrombin-phosphatidylserine (aPS/ PT) IgG / IgM. Among them, 509 women had completed their deliveries and were evaluated whether the presence of APLs was related to the pregnancy outcome such as premature delivery, gestosis, pregnancy induced hypertension (PIH), and intrauterine fetal growth restriction (IUGR).
Results: The frequency of APL was found to be 9.6%. The frequencies of each APL were as follows; aCL IgG (2.0%), IgM (0%). IgA (0.6%), aPS/ PT IgG (0.4%). IgM (7.3%). LA (0.8%). The presence of LA was found to be associated with gestosis (RR 10.0. 95%CI 2.2-46.2) and PIH (RR 9.6, 95%CI 1.0-91.0). Additionally , the presence of two or more APLs was associated with PIH (RR 9.6, 95%CI 1.0-91.0). Neither of APL was associated with premature delivery nor IUGR.
Conclusions: In this prospective study, we demonstrated the prevalence of APL among pregnant women. We for the first time demonstrated that the presence of LA and two or more APL were significant risk factors of gestosis and PIH. RESULTS: Median MIF concentrations in Group I. II, and III were 17.6. 16.4. and 15.1 ng/ml, respectively.
MIF concentrations during early gestation in RM women with subsequent MsNK. MsAK, and Lb were 8.1. 11 .4, and 16.4ng/ml, respectively. MIF concentrations in RM women with MsNK were significantly lower than those in RM women with Lb and than those in Group I. II. and III.
CONCLUSIONS: Decreased serum MIF concentrations during early gestation were found in RM women with MsNK" and might be related to etiology of miscarriage. Recently, surprisingly high prevalence of factor XII deficiency among patients with thrombosis and RPL have been reported. Since the presence of antibodies to factor XII in patients with lupus anticoagulant has been reported, we have now tested plasma samples from RPL patients for the presence of autoantibodies to factor XII and for the epitope mapping of factor XII recognized by those autoantibodies.
Methods and Results: One hundred ninety one patients with RPL were screened for factor XII activity. We found 34 (17.8%) patients with factor XII deficiency. We hypothesized that factor XII deficiency may be partly due to presence of antibodies to factor XII and tested plasma samples from patients with factor XII deficiency for the presence of antibodies to factor XII by immunoblot and ELISA. We found that 53.5% of factor XII deficient patients with RPL were positive for IgG anti-factor XII antibodies (p<0.001). All anti-factor XII antibodies recognized the heavy chain of factor XII. Several peptides were synthesized after consideration of the structure of factor XII based on literatures. and we found that anti-factor XII antibodies recognized the amino-terminal heavy chain region of factor XII.
Conclusions: Literatures have reported that human factor XII binding to the glycoprotein Ib-IX-V complex via the amino-terminal heavy chain region inhibits thorombin-induced platelet aggregation. We confirmed that patients with factor XII deficiency had antibodies to factor XII and those autoantibodies recognized the heavy chain of factor XII, especially the amino-terminal sequences. Therefore, we hypothesize that autoantibodies to factor XII may be associated with diseases, such as thrombophilia and RPL.
27. Impaired vascular function in women with recurrent pregnancy loss: Involvement of antiphospholipid antibodies Mikiya Nakatsuka, Soichi Noguchi, Yasuhiko Kamada, Chebib Chekir, Aiko Sasaki, Lin Hao, Yuji Hiramatsu Okayama University
The causes of recurrent pregnancy loss (RPL) are classified as genetic, anatomic, endocrinologic, immunologic, microbiologic, and environmental. However, vascular changes associated with RPL remain poorly studied. by reports indicating that husband's lymphocyte immunotherapy is often used to improve fertility of patients with HA, which probably acts through immune-mediated mechanisms.
Methods: By using RT-PCR-SSCP analysis, we first investigate the peripheral T cell clonality in healthy women. Next we compared the T cell clonality in HA, before and after husband's lymphocyte immunotherapy.
Similar analysis was done about the examples of one or two times addition of immunotherapy and after delivery.
Decidual analysis of two cases, early missed abortion and artificial abortion, was done. Particular TCR BV gene products of accumulationg T cell were determined by direct sequencing. Results: Although peripheral T cells in healthy women were extremely heterogeneous, non-pregnancy patients with a history of HA before immunotherapy were not. It was also revealed, however, that immunotherapy reduced the number of accumulation T cell clones. Accumulating T cell clones levels of examples of one or two times addition of immunotherapy and after delivery were similar to post-immunotherapy of HA. We determined amino acid sequences of T cell clones accumulating in TCR BV1 gene products of the RT-PCR. Dominant accumulating clone at a frequency of 43.5% in the BV1 before immunotherapy decreased to 3.1% after that therapy.
Conclusion: Our results, together with the clinical effectiveness of immunotherapy, suggest that accumulation of T cell clonotypes, which probably resulted from antigenic stimulation, is involved in the pathogenesis of HA. These findings enhance our understanding of the mechanisms by which immunotherapy might prevent rejection of the fetus in HA. Conclusions: 1) APAs were greatly involved in RSA. and significantly higher incidence was found in PE-IgG CL-IgM and PS-IgM antibodies than in other APAs. And the incidence of IgM antibodies was significantly higher than that of IgG. 2) Anticoagulation-therapy to RSA patients with any of APAs was effective, obtaining 88.2% of the high production in successful pregnancy, and the subtypes of APAs did not influence the therapeutic outcome. beta-hydroxysteroid dehydrogenase (3 beta-HSD). cytochrome P450 alpha-hydroxyiase (P450c17). cytochrome P450 aromatase (P450arom)). were studied by immunohistchemistry.
RESULTS: The number of antral follicle in human ovarian graft following transplantation/stimulation into ovarian bursa of NOD-SCID mice were 28 in 56 grafts. However. only one antral follicle was developed in 12 grafts following transplantation into mice back skin. In NOG mice. 23 antral follicle developed in 53 human ovarian grafts, and among these, graffian follicle development was observed in 2 human ovarian grafts. In this study, we investigated to produce reconstituted embryos derived from somatic cell nuclei, and to isolate undifferentiated cells from the rabbit embryos.
Mature Japanese White female rabbits were superovulated with HMG and hCG. Cumulus-oosyte complexes were obtained from oviducts, and cumulus cells were removed by hyaluronidase and pippeting . Nuclear donor cells were fibroblasts gathered from abdominal skin of Dutch strain rabbits. MII oocytes were enucleated in modified HTF medium containing cytochalasin B. The chromosome removal was confirmed by staining with Hoechst 33342 under ultraviolet light. The reconstituted embryos were produced by two methods, electorofusion and microinjection. In the electorofusion methods, a fibroblast was inserted into the perivitelline space of the enucleated oocyte using injection pipette. The pairs were induced of the cell membrane fusion using the cell fusion apparatus. After electrofusion, these oocytes were cultured for 1 hour in HTF medium . On the other hand, in microinjection methods, a single donor cell was drowning in and out of the injection pipette until the plasma membrane was broken. After, the nuclei were injected individually into enucleated ooplasm . The reconstituted oocytes were activated with 7% ethanol for 5 minutes , and exposed to 6-dimethylaminopurine (DMAP) and Cycloheximide (CHX) in HTF medium for 3 hours at room temperature to inhibit the chromosome condensation and the release of 2nd polar body. The embryos developed to blastocyst were cultured on the feeder cells layer in Ham-F12 medium.
The number of reconstituted embryos treated with DMAP and CHX was 72. The rate of cleavage to more than 8-cells stage was 38.8%. The developmental rate to blastocyst was low comparison with the control , however some embryos were confirmed development to hatching or more stage in vitro and attached on the feeder cells layer.
From the results obtained, we confirmed in vitro development to hatching and more stage of reconstituted embryos in the rabbit, and obtained attached cell population from the embryos . Further, there was no difference of attached cell populations comparison with control in morphology. It is suggest that isolation of undifferentiated cells will be possible. However. developmental rate was significantly lower than the control . It is necessary to improve culture conditions for effective development of reconstituted embryos . In domestic animals and laboratory animals, immature oocytes from ovaries have a potentiality tor mature under the in vitro culture and develop to live pups following in vitro fertilization and embryo transfer. However. there is higher incidence of embryo/fetal losses in the embryos derived from in vitro matured oocytes. compared to ovulated or in vivo matured oocytes. This study was carried out to confirm when the embryo/fetal losses were occurred through their embryonic development. Sexually matured ICR female mice were induced follicle development with injections of PMSG to collect oocytes at germinal vesicle (GV) stage from Graafian follicles. About 22 hours after injections. GV oocytes enclosed with several layers of cumulus cells were collected in HEPES-buffered HTF medium supplemented with FBS. 2-mercaptoethanol and dbcAMP. The collected GV oocytes were performed maturation culture in HTF medium supplemented with FBS, 2-mercaptoethanol, FSH, EGF, amino acids and vitamin for 18-20 hours. After maturation culture, oocytes were inseminated in HTF medium supplemented with .BSA and resultant zygotes were cultured in KSOM medium until reached to blastocyst stage. The blastocysts were subsequently co-cultured onto the murine fetal fibroblasts as feeder cells for investigation of the implantation potencies. The ovulated oocytes, as a control, were induced by injections of hCG following PMSG and removed from ampullae of females. They were operated insemination and embryo culture likewise.
After maturation culture. over 95% of collected GV oocytes extruded their first polarbodies. thus they were considered 'matured' oocytes in the metaphase of second meiosis. There was no significant difference in fertilization rate between in vitro matured and ovulated oocytes, while the developmental rate to the blastocyst in the fonner were significantly lower than the latter (32% vs. 78%). It was noted that the embryo loss in ovulated oocytes was mainly arisen at morula stage, while that in oocytes matured in vitro was arisen at every developmental stage. especially when developed to 4-cell from 2-cell. Further, regarding post-implantation stage development. it was impossible for approximate 40% of blastocysts derived from in vitro matured oocytes to attach to the feeder cells. although almost all blastocysts from ovulated oocytes were attachable. and trophoblast cells were adhered concomitantly. It was demonstrated that maturation culture extinguished oocyte viability by degrees throughout pre-/post-implantation development. Objective: Pro-inflammatory cytokines are thought to be pathogenetic elements in osteoporosis of postmenopausal women. Monocytes. which play a key role in innate immunity by producing cytokines, are influenced by sex hormones. Since hormone replacement therapy (HRT) is widely used in postmenopausal women, we investigated the effect of HRT on the production of pro-inflammatory cytokines in postmenopausal women. Results: The production of IL-1 alpha in HRT-treated women in the early (<10 years) and late ( 30 years) postmenopausal stages were significantly lower than those in untreated women at respective stages. IL-6 levels in HRT-treated women in the mid ( 10 and <30 years) and late postmenopausal stages were significantly lower than those in untreated women at respective stages. TNF-alpha levels in HRT-treated women in all postmenopausal stages were significantly lower than those in untreated women at respective stages. HRT induced a significant decrease in the production of TNF-alpha.
Conclusions: These results suggest that HRT may have an anti-inflammatory effect on pro-inflammatory cytokine production. 
